Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.
Thymic Neuroendocrine Tumors
Lausi P. O.;Filosso P. L.;Ruffini E.;Oliaro A.;Guerrera F.;
2014-01-01
Abstract
Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
008_Thymic neuroendocrine tumors.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
687.5 kB
Formato
Adobe PDF
|
687.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
